¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"interstitial lung disease with increased volume"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • foot process disease
    ¹ßµ¹±âº´
  • foot-and-mouth disease
    ÀԹߺ´, ±¸Á¦¿ª
  • Fordyce¡¯s disease
    Æ÷´ÙÀ̽ºº´
  • functional cardiovascular disease
    ±â´É¼º½É(Àå)Ç÷°üº´
  • fungal disease
    Áø±ÕÁúȯ, °õÆÎÀ̺´
  • fusospirochetal disease
    ¹æÃß±Õ½ºÇÇ·ÎÇ쟺´
  • gastroesophageal reflux disease
    À§½Äµµ¿ª·ùº´
  • genetic disease
    À¯Àüº´
  • gestational trophoblastic disease
    Àӽſµ¾ç¸·º´
  • glomerular disease
    Å丮º´, »ç±¸Ã¼Áúȯ
  • gamma chain disease
    °¨¸¶»ç½½º´
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûº´, ´ç¿øÃàÀûº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾º´
  • Greenfield¡¯s disease
    ±×¸°Çʵ庴
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • febrile disease
    ¿­º´
  • fibrocystic disease
    ¼¶À¯³¶º´
  • fibromuscular disease
    ¼¶À¯±ÙÀ°º´
  • fifth disease
    (¢¡erythema infectiosum) °¨¿°È«¹Ý
  • fishskin disease
    (¢¡ichthyosis) ºñ´ÃÁõ
  • fluke disease
    ÈíÃæº´
  • foot process disease
    ¹ßµ¹±âº´
  • foot-and-mouth disease
    ÀԹ߱Áº´, ±¸Á¦¿ª
  • functional cardiovascular disease
    ±â´É½ÉÀåÇ÷°üº´
  • fungal disease
    Áø±Õº´, Áø±ÕÁúȯ, °õÆÎÀ̺´
  • gamma chain disease
    °¨¸¶°í¸®º´
  • gastroesophageal reflux disease
    À§½Äµµ¿ª·ùº´
  • genetic disease
    À¯Àüº´
  • gestational trophoblastic disease
    Àӽſµ¾ç¸ð¼¼Æ÷º´
  • glucose storage disease
    ´çÃàÀûº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • Mu heavy chain disease
    Mu Áß¼âÁúȯ
  • Oguchis disease
    ¿À±¸Ä¡º´
  • Osler-Weber-Rendu disease
    ¿À½½·¯-¿þ¹ö-·»µÎ¾¾ º´
  • Pagets disease
    ÆÄÁ¦Æ®º´
  • Pagets disease
    ÆÄÁ¦Æ®º´.
  • Pagets disease
    ÆÄÁ¦Æ®º´
  • Pagets disease, extramammary
    À¯¹æ¿Ü ÆÄÁ¦Æ®º´.
  • Parkinsons disease
    ÆÄŲ½¼º´
  • Parkinsons disease
    ÆÄŲ½¼º´.
  • Pick s disease
    ÇȺ´.
  • Picks disease
    ÇÇÅ©º´(~Ü»)
  • Pompe disease
    ÆûÆäº´
  • Pompes disease
    ÆûÆä¾¾ º´
  • Pott s disease
    Æ÷Æ®º´ ôÃßÄ«¸®¿¡½º .
  • Potts disease
    Æ÷Æ®º´, ôÃßÄ«¸®¿¡½º .
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • volume dilatometer
    ¿ëÀûÆØÃ¢°è.
  • volume dose
    ¿ëÀû¼±·®
  • volume effect
    ¿ëÀûÈ¿°ú
  • volume elasticity
    ¿ëÀûź¼º.
  • volume elasticity coefficient
    ¿ëÀûź¼º·ü.
  • volume expander
    Ç÷·® Áõ·®Á¦
  • volume flow of blood
    Ç÷·ù·®(úìêüåÖ).
  • volume fraction
    ¿ëÀûºÐȹ.
  • volume gradient echo technique
    ¿ëÀû °æ»ç ¿¡ÄÚ ±â¹ý
  • volume implantation
    ¿ëÀûÀÚÀÔ
  • volume index
    ¿ëÀûÁö¼ö(¡­ò¦â¦).
  • volume load
    ¿ëÀûºÎÇÏ(¡­Ý¶ùÃ).
  • volume magnetic susceptibility
    ¿ëÀû ÀÚÈ­À²
  • volume modifying factor
    ¿ëÀû¼ö½ÄÀÎÀÚ, ¿ëÀû±³Á¤ÀÎÀÚ
  • volume molal
    ¿ëÀû¸ô¶ö.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
CHLD chronic hypoxic lung disease
CNSLD chronic nonspecific lung disease
COLD chronic obstructive lung disease
FLD fibrotic lung disease
LL large lymphocyte; lateral leminiscus; left lateral; left leg; left lower; left lung; lepromatous [in...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
HEL Human embryonic lung
HELF Human embryonic lung fibroblast
HFL-1 Human lung fibroblasts
HLF Human lung fibroblasts
HLMC Human lung mast cells
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • idiopathic disease
    Ư¹ßº´
    ´Ù¸¥ ÁúȯÀÇ °á°ú·Î ¹ß»ýÇÏÁö ¾Ê´Â Áúº´À¸·Î¼­, ¿øÀÎÀº ºÒ¸íÀÌ´Ù.
  • immune deficiency disease
    ¸é¿ª °áÇÌ Áúȯ, ¸é¿ª °áÇ̺´
    ¸é¿ª °èÅëÀ» ±¸¼ºÇÏ´Â ¿ä¼ÒÀÇ ±â´É Àå¾Ö¿¡ ÀÇÇÏ¿© ÃÊ·¡µÇ´Â Áúȯ ±º.
  • immunologic disease
    ¸é¿ª Áúȯ, ¸é¿ªÇÐÀû Áúȯ
  • inclusion body disease
    ºÀÀÔü º´
    ¼¼Æ÷ ºÀÀÔü°¡ ³ªÅ¸³ª´Â Áúȯ. ƯÈ÷ ¹ÙÀÌ·¯½º º´¿¡¼­ ÈçÇÏ´Ù.
  • infectious disease
    °¨¿° Áúȯ, °¨¿°¼º Áúȯ, °¨¿°º´, Àü¿°º´
    °¨¿°À» ÀÏÀ¸Å°´Â ¼÷ÁÖ´Â Á¦°¢±â º´¿øÃ¼¿¡ ´ëÇØ¼­ ƯÀ¯ÇÑ ¹ÝÀÀÀ» ³ªÅ¸³»°í ¹ÝÀÀÀÇ º´ÀûÀÎ Á¤µµ¿¡ ´ÞÇØ ÀÓ»ó Áõ»óÀÌ ³ªÅ¸³­ ÁúȯÀ» ¸»ÇÑ´Ù. °¨¿°À» ÀÏÀ¸Äѵµ ¹Ýµå½Ã ¹ßº´ÇÑ´Ù°í´Â ÇÒ ¼ö ¾ø°í ±× º´¿øÃ¼ÀÇ Á¾·ù, º´¿øÃ¼ÀÇ °¨¿°·Â¿¡ °üÇÑ ÀÎÀÚ¿Í °¨¿°ÇÑ »ýüÀÇ °¨¼ö¼º, ¸é¿ª, ±× ¹ÛÀÇ ÀúÇ׷¿¡ °üÇÑ ÀÎÀÚ¿ÍÀÇ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ¼­ °áÁ¤µÈ´Ù.
  • ischemic heart disease
    ÇãÇ÷¼º ½É Áúȯ
  • Jadassohn's disease
    ¾ß´ÙÁ¸ º´
    ¹Ý»ó ±¸Áø»ó È«ÇÇÁõ.
  • Jod-Basedow disease
    Jod-Basedow Áúȯ
    ¿ä¿Àµå À¯¹ß¼ºÀÇ °©»ó¼± ±â´É Ç×ÁøÁõ.
  • jumping disease
    ¹«µµº´
  • Kahler's disease
    Kahler º´
    ´Ù¹ß¼ºÀÇ °ñ¼öÁ¾À¸·Î ÀϹÝÀûÀÎ °ñ ¼¼Æ÷¿¡¼­ º¼ ¼ö ÀÖ´Â Á¾¾ç.
  • Kawasaki disease
    °¡¿Í»çŰ º´
    °©ÀÛ½º·± ¿­°ú Àü½Å¿¡ ¹ßÁøÀÌ ³ªÅ¸³ª´Â ¿øÀÎ ºÒ¸íÀÇ Áúȯ. 1967³â ÀϺ»¿¡¼­ óÀ½À¸·Î º¸°íµÈ µ¥¼­ ÀÌ·± º´¸íÀÌ ºÙ¾ú´Ù. È«¿ª, ¼ºÈ«¿­, dzÁø µî°ú ºñ½ÁÇÑ Áõ¼¼¸¦ º¸À̹ǷΠ°¨º°¿¡ À¯ÀÇÇØ¾ß ÇÑ´Ù. Áõ¼¼·Î´Â, ¨ç °í¿­ÀÌ 5ÀÏ ÀÌ»ó °è¼ÓµÈ´Ù. ¨è ´«ÀÌ ÃæÇ÷µÈ´Ù. ¨é ¼Õ¹Ù´Ú, ¹ß¹Ù´ÚÀÌ »¡°²°Ô ºÎ¾î¿À¸£¸é¼­ ²®ÁúÀÌ ¹þ°ÜÁø´Ù. ¨ê Àӯļ±ÀÌ º×´Â´Ù. ¨ë ÀÔ¼úÀÌ ºÓ¾îÁø´Ù. ¨ì Àü½Å ¹ßÁø Áõ¼¼ µîÀ» º¸À̴µ¥, ÀÌ °¡¿îµ¥ 5°¡Áö ÀÌ»óÀÇ Áõ¼¼¸¦ º¸À̸é ÀÌ º´À» ÀǽÉÇØ¾ß ÇÑ´Ù. ¹ÙÀÌ·¯½º °¨¿°¼³, Áß¼º ¼¼Á¦¼³, Ä­µð´Ù ¼¼±Õ¼³ µîÀÌ ¿øÀÎÀ̶ó´Â Çм³ÀÌ Á¦±âµÇ¾úÀ¸³ª È®½ÇÇÏ°Ô ¹àÇôÁöÁö ¾Ê°í ÀÖ´Ù. 90 % ÀÌ»óÀÌ 1~4¼¼ÀÇ ¿µ, À¯¾Æ±â¿¡ ¹ßº´Çϸç, ¿©¾Æº¸´Ù´Â ³²¾Æ¿¡°Ô ÁÖ·Î ¹ßº´ÇÑ´Ù. ¶ÇÇÑ ¹ßº´·üÀÌ ¼­¾çÀκ¸´Ù µ¿¾çÀο¡°Ô ³ô´Ù. ¿¹¹æ¹ýÀº ÇöÀç µû·Î ¾ø°í Áõ¼¼¸¦ º¸ÀÎ ÈÄ 2~3ÁÖ¸é ÀÚ¿¬ Ä¡À¯µÇ³ª ½ÉÀå ÇÕº´ÁõÀ» ÀÏÀ¸ÄÑ ±Þ»çÇÒ À§ÇèÀÌ ÀÖ´Â Áúº´À̱⵵ ÇÏ´Ù. µû¶ó¼­ Á¶±â¿¡ ¹ß°ßÇÏ¿© ÇÕº´ÁõÀ» ¿¹¹æÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù. Çѱ¹¿¡¼­´Â 73³â óÀ½À¸·Î ¹ß°ßµÈ ÀÌ·¡ 91³â 1, 228¸íÀÌ ¹ßº´, º¸°íµÇ¾ú´Ù.
  • Kimura disease
    Ű¹«¶ó º´
    ûÀå³â±âÀÇ ¿©ÀÚ¿¡°Ô ÁÖ·Î ¹ß»ýµÇ´Â ¸Æ¶õ¼º Áõ½Ä¼º º´¼ÒÀÌ´Ù. µÎ°æºÎ ÇÇÇÏ Á¶Á÷À̳ª ±¸°­³» ¶Ç´Â »ó¼ø ³»Ãø¿¡¼­ Àß ¹ß»ýµÇ¸ç ÀÌÇϼ± ºÎÀ§¿¡¼­µµ ÀÚÁÖ º¸ÀδÙ. Á¶Á÷ÇÐÀûÀ¸·Î ÀÌÇü¼º Ç÷°ü ³»ÇÇ ¼¼Æ÷ÀÇ Áõ½Ä°ú ¸¸¼º ¿°Áõ ¼¼Æ÷ÀÇ Ä§À±, È£»ê±¸ÀÇ Ä§À±ÀÌ ÀÖ°í ½ÉÇϸé È£»ê±¸ ³ó¾çµµ Çü¼ºÇÏ¸ç ¸²ÇÁ Á¶Á÷ÀÇ Áõ»óÀ» º¸ÀδÙ. Ÿ¾×¼± Á¶Á÷Àº À§ÃàµÇ°í ÀÖ´Ù.
  • Lane's disease
    ·¹ÀÎ º´
    ¸¸¼º Àå Æó»öÁõ.
  • Langdon-Down's disease
    ·©µ·-´Ù¿î º´
  • Larsen-Johansson disease
    ¶ó¸£¼¾-¿äÇѽ¼ º´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
lung: gallium imaging <radiology> Scans at 48 hrs because 50% of normals show activity at 24 hrs, focal uptake, primary pulmonary malignancy, benign disorder: granuloma, abscess, pneumonia, silicosis, multifocal/diffuse uptake, infection, TB: active lesion, miliary TB, rapidly progressive TB pneumonia, PCP: unimpressive symptoms and CXR, CMV, inflammation: sarcoid, interstitial lung disease (pneumoconiosis, idiopathic pulmonary fibrosis, lymphangitic carcinomatosis), radiation pneumonitis, drugs: bleomycin, amiodarone, contrast lymphangiography (in 50%) see: gallium: indications, uptake with normal chest film
(12 Dec 1998)
lung-grown <medicine> Having lungs that adhere to the pleura.
Source: Websters Dictionary
(01 Mar 1998)
lung, hyperlucent Hyperlucency of one lung with decreased size and vascularity of the lung. It is often associated with bronchiolitis obliterans and with adenovirus infection in childhood.
(12 Dec 1998)
lung perfusion agents <radiology> Tc-99m MAA (macro-aggregated albumin), Tc-99m HAM (human albumin microspheres), dose 4 mCi, particles, size 10 - 90 m, number 200,000 - 400,000, effect 1 : 1000 arterioles embolised
(12 Dec 1998)
lung segmental anatomy <radiology> Right lung, 3 lobes, 10 segments, left lung, 2 lobes, 8 segments
(12 Dec 1998)
lung transplantation The transference of either one or both of the lungs from one human or animal to another.
(12 Dec 1998)
lung unit A respiratory bronchiole together with the alveolar ducts and sacs and pulmonary alveoli into which the respiratory bronchiole leads, considered by some to include the terminal bronchiole and its subdivisions, and called a pulmonary acinus.
(05 Mar 2000)
lung ventilation agents <radiology> Xe-133, most commonly used, Xe-127, t = 36.4 days; photons @ 172, 203, 375 keV, can image V after Q, Kr-81m, very expensive, t = 13 sec; photon 190 keV, can repeat V in each projection, Tc-99m DTPA aerosol, can image V in mult. Projections, image Q after V, 1 mCi most likely to be 50-75 mrad to lung, V/Q imaging
(12 Dec 1998)
lung window CT settings of window level and width appropriate to showing lung detail; soft tissues are white or nearly so.
Mediastinal window, CT settings of window level and width appropriate to showing soft tissue structures; the lungs become black at these settings.
Synonym: soft tissue window.
(05 Mar 2000)
lymphangitic lung metastases <radiology> Usually adenocarcinoma, breast, lung, upper GI tract (stomach, pancreas)
(12 Dec 1998)
aaa disease Endemic anaemia of ancient Egypt, ascribed in the Papyrus Ebers to intestinal infestation with ancylostoma; now called ancylostomiasis.
(05 Mar 2000)
ABO haemolytic disease of the newborn Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes.
(05 Mar 2000)
accumulation disease A disease characterised by abnormal accumulation of a metabolic product in certain cells and tissues; examples include the mucopolysaccharidoses, lipoidoses.
(05 Mar 2000)
Acosta's disease A condition that results from prolonged exposure to high altitude.
Symptoms include a continuous dry cough, shortness of breath, poor exercise tolerance, dizziness, headache, sleep difficulty, anorexia, confusion, fatigue and a rapid pulse.
Treatment includes the immediate movement to a lower altitude. Prophylaxis has been accomplished successfully with the use of acetazolamide (Diamox).
(27 Sep 1997)
acquired immunodeficiency disease Acquired immunodeficiency disease: Disease caused by infection with the human immunodeficiency virus (HIV).
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
ÅëÇÕ°Ë»ö ¿Ï·á